Back | Next |
home / stock / acst / acst message board
Subject | By | Source | When |
---|---|---|---|
LOADED THE BOAT at $1.52. Lets do this. | Disquisition | investorshub | 11/17/2021 11:50:04 PM |
$ACST - Acasti Pharma Awarded Composition-of-Matter Patents for | Eurotradr | investorshub | 10/06/2021 12:34:18 PM |
Loaded $1.98, lets ?? | xLeGenDx | investorshub | 09/21/2021 5:57:35 PM |
$ACST...$2.22...Bullish Descent Block Reversal Pattern to the Upside | georgie18 | investorshub | 09/09/2021 9:44:16 AM |
znewcar1: ACST 565% v3,0M c2.67 f26M f was f208M@$.54 | znewcar1 | investorshangout | 08/31/2021 8:44:58 PM |
whytestocks: $ACST News Article - Why Shares of Acasti Pharma Slumped Tuesday | whytestocks | investorshangout | 08/31/2021 6:35:48 PM |
Hard to catch a falling knife. | Monksdream | investorshub | 08/31/2021 3:34:57 PM |
Back in. | kzivann | investorshub | 08/31/2021 2:12:12 PM |
You ain't kidding. All the shareholders prior to | Monksdream | investorshub | 08/31/2021 1:47:11 PM |
INDEFATIGABLE DUMPING | Disquisition | investorshub | 08/31/2021 1:34:22 PM |
Watch after RS. | kzivann | investorshub | 08/31/2021 12:45:46 PM |
$ACST/$ACSTX...$30.40...1/8 Reverse Split...https://www.otcmarkets.com/filing/html?id=15192357&g | georgie18 | investorshub | 08/31/2021 10:38:42 AM |
Very nice premarket.. | kzivann | investorshub | 08/27/2021 12:51:57 PM |
Got some... | kzivann | investorshub | 08/26/2021 2:18:28 PM |
I am as well... | georgie18 | investorshub | 08/02/2021 5:06:50 PM |
Still holding a nice position here. | GREGG THE GREEK | investorshub | 08/02/2021 4:21:03 PM |
$ACST...4668...Forming a strong confirmation candle following the Bullish | georgie18 | investorshub | 07/28/2021 2:14:40 PM |
Adding some back here. | GREGG THE GREEK | investorshub | 07/14/2021 1:46:37 PM |
$ACST...57...in the P/M...on the Gappa...:partying face: | georgie18 | investorshub | 07/14/2021 12:45:30 PM |
As part of the Acasti annual and special | Eurotradr | investorshub | 07/14/2021 11:52:33 AM |
News, Short Squeeze, Breakout and More Instantly...
Projected Cash Runway Extends into Second Calendar Quarter 2026, Well Beyond Potential 1H 2025 Submission of GTX-104 New Drug Application (NDA) Patient Enrollment in Pivotal STRIVE-ON Phase 3 Trial Continues, On Track for NDA Submission Timeline Poster Highlighting the STRIVE-ON...
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (Acasti or the Company), a late-stage, biopharma company adv...
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel formulation of nimodipine that addresses the high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (...